Director/PDMR Shareholdings

RNS Number : 9607W

Integumen PLC

16 December 2019

 

16 December 2019

Integumen PLC

("Integumen" or "Company")

Director/PDMR Shareholdings

Further to the announcement released by the Company on 9 December 2019, and following admission of 91,253,530 new Ordinary Shares to trading on AIM ("Admission") this morning, Integumen announces the following PDMR Shareholdings arising as a result of the Ordinary Shares issued and allotted pursuant to the Subscription.

The following table sets out details of the Directors' share dealings and resulting interests in the Company's issued share capital:

Director	Shares subscribed for on 9 December 2019	Resulting interest	Resulting interest (%)
Gerard Brandon	1,084,511	50,199,012	4.68%
Camillus Glover	1,084,510	42,506,704	3.96%
Fionán Murray	1,084,510	87,867,578	8.19%

Total Voting Rights

Following Admission, the Company's issued share capital consists of 1,072,416,903 ordinary shares of 0.01 pence each.

The above figure of 1,072,416,903 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

Market Abuse Regulation (MAR) Disclosure

Certain information contained in this announcement would have been deemed inside information for the purposes of Article 7 of Regulation (EU) No 596/2014 until the release of this announcement.

Capitalised terms used in this announcement shall have the same meaning as in the announcement released by the Company on 9 December 2019.

Enquiries:

Integumen plc	Gerard Brandon, CEO	[phone]
SPARK Advisory Partners Limited (Nominated Adviser)	Neil Baldwin	[phone]
Turner Pope Investments (TPI) Limited (Broker)	Andy Thacker/Zoe Alexander	[phone]

About Integumen: www.integumen.com

Integumen is a vertically integrated product and services company for skin related diseases, treatments and therapies with four business units: 

·      Labskin AI's technology platform incorporates artificial intelligence within clinical research for medical device, pharmaceuticals, cosmeceuticals and related life science test services.  Labskin allows skincare, healthcare, pharmaceutical manufacturers and cosmetic companies to test their products on human-like skin in a real-world environment with full access to multiple state-of-the-art partner technologies.

·      Rinodrive is a data aggregation, refining and AI analysis open-source eco-system designed to provide third-party service providers the ability to offer their clients valuable insights that support clinical, operational and financial decisions in healthcare services, third-level education, government departments and the financial sector.

·      Wound pHase is developing skin and wound care products using its proprietary wound dressing technology. Working in collaboration with CBD providers creating a CBD infused diabetic wound care product range.

·      Stoer-for-men skin products e-commerce division offers a range of skincare products derived from 5 natural super-ingredient plant extracts specifically for men to reduce the signs of ageing and is also used as a control for client testing within Labskin laboratories.

FORM FOR NOTIFYING DEALINGS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

1	Details of the person discharging managerial responsibilities/person closely associated
a)	Name		Gerard Brandon
2	Reason for the notification
a)	Position/status		Chief Executive Officer (PDMR)
b)	Initial notification/ Amendment		Initial
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name		Integumen PLC
b)	LEI		213800M477RQVVHVUD72
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	Ordinary shares of 0.01 pence each Identification code GB00BYWJ6269
b)	Nature of the transaction	Acquisition of ordinary shares (subscription)
c)	Price(s) and volume(s)	Price(s) Volume(s) 1.5 pence 1,084,511
d)	Aggregated information - Aggregated volume and Price	Price(s) Volume(s) 1.5 pence 1,084,511 Total - £16,267.67
e)	Date of the transaction	16 December 2019
f)	Place of the transaction	X.LON

1	Details of the person discharging managerial responsibilities/person closely associated
a)	Name		Camillus Glover
2	Reason for the notification
a)	Position/status		Chief of Finance and Operations (PDMR)
b)	Initial notification/ Amendment		Initial
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name		Integumen PLC
b)	LEI		213800M477RQVVHVUD72
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	Ordinary shares of 0.01 pence each Identification code GB00BYWJ6269
b)	Nature of the transaction	Acquisition of ordinary shares (subscription)
c)	Price(s) and volume(s)	Price(s) Volume(s) 1.5 pence 1,084,510
d)	Aggregated information - Aggregated volume and Price	Price(s) Volume(s) 1.5 pence 1,084,510 Total - £16,267.65
e)	Date of the transaction	16 December 2019
f)	Place of the transaction	X.LON

1	Details of the person discharging managerial responsibilities/person closely associated
a)	Name		Fionán Murray
2	Reason for the notification
a)	Position/status		Group Sales Director (PDMR)
b)	Initial notification/ Amendment		Initial
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name		Integumen PLC
b)	LEI		213800M477RQVVHVUD72
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	Ordinary shares of 0.01 pence each Identification code GB00BYWJ6269
b)	Nature of the transaction	Acquisition of ordinary shares (subscription)
c)	Price(s) and volume(s)	Price(s) Volume(s) 1.5 pence 1,084,510
d)	Aggregated information - Aggregated volume and Price	Price(s) Volume(s) 1.5 pence 1,084,510 Total - £16,267.65
e)	Date of the transaction	16 December 2019
f)	Place of the transaction	X.LON

 

END

 

 

DSHTFBPTMBJBMLL